Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Rhea-AI Summary

Harvard Bioscience (NASDAQ: HBIO) has announced it will release its financial results for Q1 2025 (quarter ended March 31, 2025) before market opens on May 12, 2025. The company will host a conference call at 8:00 AM Eastern Time to discuss the results. Interested participants who wish to ask questions must pre-register to receive dial-in numbers and a unique PIN. An audio-only webcast option is also available through the company's investor website. The earnings release and related presentation materials will be accessible through Harvard Bioscience's Investor Relations section.

HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com      

FAQ

When will Harvard Bioscience (HBIO) report Q1 2025 earnings?

Harvard Bioscience will report Q1 2025 earnings before market opens on May 12, 2025.

What time is Harvard Bioscience's Q1 2025 earnings conference call?

The earnings conference call is scheduled for 8:00 AM Eastern Time on May 12, 2025.

How can I participate in Harvard Bioscience's Q1 2025 earnings call?

Participants must pre-register to receive dial-in numbers and a PIN for asking questions, or can join the audio-only webcast through the company's investor website.

Where can I find Harvard Bioscience's Q1 2025 earnings materials?

The earnings release and related presentation materials will be available on the Investor Relations section of Harvard Bioscience's website.